We’re excited to announce that our work for two of our clients has been recognized by the Summit Awards. The KBC Houston received a gold award for its company rebranding, and Brightfield Therapeutics received a bronze award for its logo design. Read more about each company and its accomplishments in our latest newsroom. https://lnkd.in/g9A4Gezg #SummitCreativeAwards #branding #creativedesign
Robot Creative’s Post
More Relevant Posts
-
Merz Group, a globally diversified company in Frankfurt, Germany, has three businesses—Merz Aesthetics, Merz Therapeutics, and Merz Consumer Care. The company has been family-owned for more than 110 years, and is distinguished by its commitment to innovation, long-term perspective, and focus on profitable growth. That’s why they partnered with CSC, an enterprise-class provider, to implement a global #domainpolicy and consolidate their #digitalprofile. https://lnkd.in/eDjRRbEJ
To view or add a comment, sign in
-
Risk-adjusted landscape for Western Digital( $WDC ), Thermo Fisher( $TMO ), Humana( $HUM ), Kimberly Clark( $KMB ), Cognizant Technology( $CTSH ), Equifax( $EFX ), PPL( $PPL ), Tenet Healthcare( $THC ), Beam Therapeutics( $BEAM ), NVIDIA( $NVDA ), Ecolab( $ECL ) and Moodys( $MCO ) https://lnkd.in/gMPwr6jr
To view or add a comment, sign in
-
📆 Join Reorg on July 10, 2024, at 2 p.m. ET for an in-depth analysis of Bausch Health Companies Inc.'s strategies to navigate its impending maturity wall, especially in the wake of recent patent developments for its blockbuster drug, Xifaxan. We'll also explore the potential impact of Bausch's financial restructuring on the future disposition of its stake in B+L. Don't miss this critical discussion—register now! https://ow.ly/9cM350SxTqY #FinanceWebinar #PharmaIndustry #FinancialRestructuring
To view or add a comment, sign in
-
-
Register now: https://loom.ly/L3Auzbw Join experts from Mayne Pharma, Archbow Consulting and AssistRx on Oct. 8 at 1 p.m. ET to explore the strategies improving visibility and access at the retail channel. During the webinar, we’ll detail how the perfect blend of tech and talent can provide specialty-lite and retail patients with specialty-level access support. #InformedAccess #ImprovedOutcomes
To view or add a comment, sign in
-
-
A Senior Advisor in Lazard’s Global Healthcare Group, Stephen Sands has guided high-impact transactions that have shaped the biotech and pharma landscape. In this episode, he shares his thoughts on what makes a successful partnership or acquisition. Listen to the full episode with Hercules Capital's Janice Bourque, here: https://lnkd.in/egXdgN3F
To view or add a comment, sign in
-
Thoughts on this? >> Bob Langer, Flagship's Stephen Berenson to depart Moderna's board as Carlyle co-founder joins >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #productmarketing #healthcare #pharma #pharmaceutical #biotech
To view or add a comment, sign in
-
Please join us on Sept 12th for this insightful discussion on best practices for reverification season!
Register now: https://loom.ly/L3Auzbw Only one day left to register for our webinar, Rethink Your Annual Reverification Strategy: No More Blizzards, happening live tomorrow at 1 p.m. ET. Join Apellis Pharmaceuticals' Patient Services Director Tasha Scott, JM DREW, LLC's Founder & Managing Member, Jim Drew, and AssistRx's Vice President of Business Development, Brok W. Vandersteen, for a deep dive into how the right annual reverification strategy balances tech + talent to meet program goals. #InformedAccess #ImprovedOutcomes
To view or add a comment, sign in
-
-
Thoughts on this? >> Bob Langer, Flagship's Stephen Berenson to depart Moderna's board as Carlyle co-founder joins >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #productmarketing #biotech #pharmaceutical #healthcare
To view or add a comment, sign in
-
A successful commercialization strategy relies heavily on robust data. To learn more, read our complete case study on closing market access gaps: https://ow.ly/PzRF50U9zpY. Pharma companies must understand where patient access is available and where it is lacking. One company collaborated with MMIT to enhance patient access to its ophthalmic therapies by utilizing MMIT's Analytics, Payer Landscape, and FormTrak tools. Download the case study now. #MarketAccess #PatientAccess #PayerInsights #PharmaceuticalIndustry #OphthalmicTherapies
To view or add a comment, sign in
-
-
🎉 AUTOMA+ 2025 is excited to welcome another leading company joining us for the second time - our Platinum Sponsor SCARLETRED Holding GmbH 🎉 🔝 SCARLETRED is the global leader in standardised skin imaging and AI-powered objective skin analysis. The company provides cutting-edge software to biopharma, biotech, cosmetics companies, clinical research organisations and healthcare experts. Their certified, ICH-GCP and EU-GDPR compliant mobile medical device software, Scarletred® Vision, is the first digital solution for skin assessment in pre-clinical, clinical and post-marketing studies. The scalable platform enables on-site and home-based monitoring of dermatologic diseases and drug effects, reducing time and costs via flexible SaaS agreements. Many thanks to SCARLETRED for supporting AUTOMA+ 2025! 🙏🏻 📍 The Pharmaceutical Automation and Digitalisation Congress 2025 is taking place on 24-25 November in Vösendorf, Austria. Join our community to be aware of the latest innovations in the pharma industry. The registration is already open! Learn more ➡️ https://lnkd.in/dypiGXcd #AUTOMAplus2025 #AUTOMAplusnews #sponsor
To view or add a comment, sign in
-